moderate-to-severe psoriasispsoriasisUstekinumabEtanerceptIxekizumabBrodalumabTildrakizumabGuselkumab=21,5 (N=23); IxekizumabRisankizumabAdalimumab
…d therapeutic optimisation.Results A total of 346 patients with moderate-to-severe psoriasis treated with biologics were included in the study, of which 286…